切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2019, Vol. 08 ›› Issue (01) : 58 -62. doi: 10.3877/cma.j.issn.2095-3232.2019.01.014

所属专题: 文献

临床研究

超声引导下经皮非接触式热消融治疗邻近腹壁肝包膜下肝细胞癌
曾庆劲1, 李凯1, 吴宇轩1, 谭雷1, 龙颖琳1, 罗丽萍1, 黄倩楠1, 许尔蛟1,(), 郑荣琴1   
  1. 1. 510630 广州,中山大学附属第三医院超声科 广东省肝脏疾病研究重点实验室
  • 收稿日期:2018-11-18 出版日期:2019-02-10
  • 通信作者: 许尔蛟
  • 基金资助:
    国家重点研发计划(2017YFC0112000); 国家自然科学基金重点项目(81430038); 国家自然科学基金(81401434); 广东省科技计划项目(2017A020215082,2017A020215137); 广州市科技计划项目(201704020164)

Ultrasound-guided percutaneous non-contact thermal ablation for sub-capsular hepatocellular carcinoma adjacent to abdominal wall

Qingjin Zeng1, Kai Li1, Yuxuan Wu1, Lei Tan1, Yinglin Long1, Liping Luo1, Qiannan Huang1, Erjiao Xu1,(), Rongqin Zheng1   

  1. 1. Department of Ultrasound, the Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou 510630, China
  • Received:2018-11-18 Published:2019-02-10
  • Corresponding author: Erjiao Xu
  • About author:
    Corresponding author: Xu Erjiao, Email:
引用本文:

曾庆劲, 李凯, 吴宇轩, 谭雷, 龙颖琳, 罗丽萍, 黄倩楠, 许尔蛟, 郑荣琴. 超声引导下经皮非接触式热消融治疗邻近腹壁肝包膜下肝细胞癌[J]. 中华肝脏外科手术学电子杂志, 2019, 08(01): 58-62.

Qingjin Zeng, Kai Li, Yuxuan Wu, Lei Tan, Yinglin Long, Liping Luo, Qiannan Huang, Erjiao Xu, Rongqin Zheng. Ultrasound-guided percutaneous non-contact thermal ablation for sub-capsular hepatocellular carcinoma adjacent to abdominal wall[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(01): 58-62.

目的

探讨超声引导下经皮非接触式热消融治疗邻近腹壁肝包膜下肝细胞癌(肝癌)的疗效。

方法

回顾性分析2012年1月至2015年12月在中山大学附属第三医院接受治疗的30例肝癌患者临床资料。其中男24例,女6例;年龄28~72岁,中位年龄56岁。病灶最大径10~40 mm,中位最大径20 mm。患者均签署知情同意书,符合医学伦理学规定。超声引导下经皮经肝穿刺消融,经正常肝组织从肿瘤深面而不直接穿刺肿瘤消融,对于有供瘤动脉的病灶先行消融阻断。观察完全消融率、并发症发生情况。

结果

射频消融19例,微波消融11例,共31个病灶。仅1例1个边缘病灶残留,完全消融率为97%(30/31)。术中采用人工腹腔积液12例,人工胸腔积液1例,人工胸、腹腔积液3例,无辅助手段14例。无发生术中及术后穿刺部位活动性出血,无发生术后并发症。随访过程中17例出现肝内复发,未发现肝周及腹腔肿瘤种植。

结论

对于邻近腹壁肝包膜下肝癌,超声引导下经皮热消融经正常肝组织穿刺,行非接触式消融,并采用人工辅助手段,可以实现安全、有效的治疗目的。

Objective

To evaluate the clinical efficacy of ultrasound-guided percutaneous non-contact thermal ablation in the treatment of sub-capsular hepatocellular carcinoma (HCC) adjacent to abdominal wall.

Methods

Clinical data of 30 patients with sub-capsular HCC treated in the Third Affiliated Hospital of Sun Yat-sen University from January 2012 to December 2015 were retrospectively analyzed. Among them, 24 patients were male and 6 were female, aged from 28 to 72 years with a median age of 56 years. The maximum diameter of the lesions ranged from 10 to 40 mm, and the median diameter was 20 mm. The informed consents of all patients were obtained and the local ethical committee approval was received. Ultrasound-guided percutaneous trans-hepatic ablation was performed through the normal liver tissues to the deep side of tumor rather than directly puncturing through the tumors. Lesions involving tumor blood supply arteries were ablated primarily. The complete ablation rate and the incidence of postoperative complications were observed.

Results

Radiofrequency ablation was performed in 19 cases and microwave ablation in 11 cases with a total of 31 lesions. The residual margin lesion was found in only 1 case. The complete ablation rate was 97%(30/31). Intraoperatively, artificial abdominal ascites were performed in 12 cases, artificial pleural ascites in 1 case, artificial pleural and abdominal ascites in 3 cases, and no auxiliary interventions in 14 cases. No active bleeding occurred at the puncture site during and after operation. No postoperative complications were observed. During the postoperative follow-up, intra-hepatic recurrence occurred in 17 cases. No tumors were found at the peri-liver area or the abdominal cavity.

Conclusions

For the sub-capsular HCC adjacent to abdominal wall, ultrasound-guided percutaneous thermal ablation through the normal liver tissues in a non-contact way, combined with artificial auxiliary interventions, can achieve a safe and efficacious treatment.

图1 一例紧邻腹壁肝包膜下肝癌患者射频消融治疗过程影像检查图
[1]
Peng ZW, Lin XJ, Zhang YJ, et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study[J]. Radiology, 2012, 262(3):1022-1033.
[2]
Tombesi P, Di Vece F, Sartori S. Resection vs thermal ablation of small hepatocellular carcinoma: what's the first choice?[J]. World J Radiol, 2013, 5(1):1-4.
[3]
丁建民,经翔,王彦冬,等.射频和微波消融治疗肝癌并发症分析[J].中华超声影像学杂志,2013, 22(6):500-504.
[4]
Yang B, Zou J, Xia J, et al. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation[J]. Eur J Radiol, 2011, 79(2):196-200.
[5]
Filippousis P, Sotiropoulou E, Manataki A, et al. Radiofrequency ablation of subcapsular hepatocellular carcinoma: single center experience[J]. Eur J Radiol, 2011, 77(2):299-304.
[6]
European Association For The Study Of The Liver1, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol, 2012, 56(4):908-943.
[7]
Kim KR, Thomas S. Complications of image-guided thermal ablation of liver and kidney neoplasms[J]. Semin Intervent Radiol, 2014, 31(2):138-148.
[8]
中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.肝癌局部消融治疗规范的专家共识[J].中华肝脏病杂志,2011, 19(4):257-259.
[9]
American Association for the Study of Liver Diseases, Bruix J, Sherman M. Management of hepatocellular carcinoma: an update[J]. Hepatology, 2011, 53(3):1020-1022.
[10]
Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2012, 379(9822):1245-1255.
[11]
Dietrich CF, Lorentzen T, Appelbaum L, et al. EFSUMB Guidelines on interventional ultrasound (INVUS), part III-abdominal treatment procedures (long version)[J]. Ultraschall Med, 2016, 37(1):E1-32.
[12]
Francica G, Meloni MF, de Sio I, et al. Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: safety and efficacy[J]. Eur J Radiol, 2016, 85(4): 739-743.
[13]
Kang TW, Lim HK, Lee MW, et al. Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study[J]. Radiology, 2016, 280(1):300-312.
[14]
Ding J, Zhou Y, Wang Y, et al. Percutaneous microwave ablation of exophytic tumours in hepatocellular carcinoma patients: safe or not?[J]. Liver Int, 2017, 37(9):1365-1372.
[15]
Park SI, Kim IJ, Lee SJ, et al. Angled cool-tip electrode for radiofrequency ablation of small superficial subcapsular tumors in the liver: a feasibility study[J]. Korean J Radiol, 2016, 17(5):742-749.
[16]
Liu CH, Yu CY, Chang WC, et al. Computed tomographic-guided percutaneous radiofrequency ablation with hydrodissection of hepatic malignancies in the subcapsular location: evaluation of safety and technical efficacy[J]. J Chin Med Assoc, 2016, 79(2):93-100.
[17]
郭光辉,许尔蛟,郑荣琴,等.单肺通气联合人工胸水辅助经皮热消融治疗肝膈顶部肝癌[J].中华超声影像学杂志,2015, 24(11): 959-962.
[18]
Thamtorawat S, Limsuwarn P, Tongdee T, et al. Incidence of complication and tumor recurrence after radiofrequency ablation in high-risk location of hepatocellular carcinoma patients[J]. J Med Assoc Thai, 2014, 97(1):95-100.
[19]
张俊超,林苏,朱月永.射频消融治疗临近特殊部位肝癌的并发症及预防[J].临床肝胆病杂志,2017, 33(5):969-973.
[20]
谢广伦,储勤军,管生,等.清醒镇静镇痛状态下肝癌射频消融术临床观察[J].中华放射学杂志,2009, 43(11):1224-1225.
[21]
李凯,曾庆劲,郑荣琴,等.超声引导经皮肝癌射频消融术中疼痛程度与病灶位置的关系[J/CD].中华医学超声杂志(电子版),2012, 9(8):682-686.
[1] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[2] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[3] 陈忠垚, 陈胜灯, 李秋. 不同手术时机对原发性肝癌自发破裂出血患者远期预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 518-521.
[4] 孟令展, 朱震宇. 达芬奇机器人辅助肝中叶切除术[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 373-373.
[5] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[6] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[7] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[8] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[9] 韩冰, 顾劲扬. 深度学习神经网络在肝癌诊疗中的研究及应用前景[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 480-485.
[10] 何传超, 肖治宇. 晚期肝癌综合治疗模式与策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 486-489.
[11] 王楚风, 蒋安. 原发性肝癌的分子诊断[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 499-503.
[12] 顾娇娇, 邹燕, 陈奕辰, 黄师菊, 张慧玲, 林楠. 基于简易营养评价精法评估肝癌患者出院后营养状况及其影响因素[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 534-539.
[13] 孟令展, 李虎, 俞鹏, 于燕宾, 曹李, 翟伟, 高远, 邵艳玲, 严锦, 朱震宇. ICG荧光染色在肝癌腹腔镜解剖性肝切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 557-561.
[14] 廖承煜, 江斌华, 黄龙, 王丹凤, 田毅峰, 陈实. 腹腔镜下肝左叶肝内胆管细胞癌根治术优化三步法的应用价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 395-400.
[15] 赫嵘, 贾哲, 张珂, 李代京, 张萌, 蒋力. 基于PSM分析腹腔镜肝切除联合Hassab术治疗合并门静脉高压症肝癌疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 376-383.
阅读次数
全文


摘要